Industry News
BioDiem moves to animal trials in pneumocystosis
BioDiem (ASX:BDM) has said its antimicrobial candidate BDM-I is ready for preclinical trials against Pneumocystosis, a parasitic fungus that can cause pneumonia. [ + ]
Bringing stem cell researchers together
This week, experts from around Australia and two international leaders in the field will meet to discuss stem cell science and just how close we are to delivering on the promise of this field. [ + ]
National Centre for Neuroimmunology and Emerging Diseases
A new centre dedicated to research on the interaction between the nervous system and the immune system has been established on the Gold Coast. [ + ]
Invisibility cloak for thermal flow
Researchers have demonstrated that metamaterials can be used to specifically influence the propagation of heat. [ + ]
New technique to improve quality control of lithium-ion batteries
Researchers have created a new tool to detect flaws in lithium-ion batteries as they are being manufactured; a step towards reducing defects and inconsistencies in the thickness of electrodes that affect battery life and reliability. [ + ]
Biosensor that detects antibiotic resistance brings us closer to fighting superbugs
JoVE has published research that demonstrates how a biosensor can detect antibiotic resistance in bacteria. The technology is a preliminary step in identifying and fighting superbugs. [ + ]
Cellmid to buy Advangen Japan in $4m deal
Cellmid (ASX:CDY) will pay around $4m in cash and stock to acquire Advangen Japan and, with it, the hair growth technology platform behind Cellmid’s evolis line. [ + ]
Mystery disease solved by gene experts
A global team of researchers has identified the gene behind an Australian toddler’s paediatric brain disorder in a discovery that is paving the way for the diagnosis and treatment of other children with genetic diseases. [ + ]
New member for Prima board
Prima Biomed (ASX: PRR) has announced a new board member, Dr Russell Howard. [ + ]
Understanding honeybee hives
The unsustainable rate at which bee colonies are failing is driving work in understanding the conditions in which colonies flourish and those in which they fail. [ + ]
Concern over NSW indemnity insurance impact on clinical trials prompts survey
Members of AusBiotech are invited to participate in a survey to gauge the impact of the 2011 increase in the Clinical Trial Indemnity Insurance Compliance Requirement. [ + ]
Patrys study confirms PAT-SM6 effect in myeloma
A scientific article details the cancer cell killing effect that Patrys’ (ASX:PAB) anticancer antibody PAT-SM6 has in multiple myeloma. [ + ]
Royal Fellowship for Australian scientists
Three Fellows from the Australian Academy of Science have been elected to the prestigious Royal Society in the United Kingdom, the oldest scientific academy in the world. [ + ]
Iluvien launches in Germany
pSivida (ASX:PVA) licensee Alimera Sciences has followed up the launch of DME treatment Iluvien in the UK with the first commercial sale in Germany. [ + ]
Novogen appoints new CSO
Novogen (ASX:NRT) has announced two new executive appointments - a CSO, as well as a president and CEO of its new North American subsidiary. [ + ]
